Important Update Regarding Semaglutide and Tirzepatide Availability

In light of a recent directive from the U.S. Food and Drug Administration (FDA), most compounding pharmacies will no longer be permitted to produce semaglutide and tirzepatide.

Please understand, this decision is not related to safety or effectiveness of these medications, which have transformed the lives of so many. Instead, this change stems from pressure by large pharmaceutical companies seeking to protect their exclusive profit margins.

At NeuVitality Buford, we are heartbroken to share this news with our valued members and guests. We have seen firsthand how impactful this medical weight loss program has been—empowering individuals, restoring health, and building confidence.

Please know: our medical team has worked urgently and tirelessly to secure a new supplier for these weight loss medications for our current and prospective patients. We are confident that our members and guests will be pleased with the quality and effectiveness of the updated skinny shot.

We are doing everything we can to preserve access to these powerful tools for those who need them most.

If you are interested in securing your own personal supply of semaglutide or tirzepatide, we urge you to contact us immediately. Once our sourcing efforts are finalized, we will reach out to those on our interest list to complete the appropriate medical evaluation and transaction.

As always, only medically qualified individuals will be eligible for this program. NEUVITALITY Buford remains fully committed to the highest standard of care, and a full practitioner review will still be required for participation.

We understand the urgency and will continue to update our community with transparency, care, and compassion. Thank you for trusting NEUVITALITY Buford as your partner in wellness.

The NeuVitality Buford Team

📞 Call or text: (770) 726-8721

📧 Email:contact@neuvitality.com

🌐 www.neuvitality.com